Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Novo Biosciences

Novo Biosciences
2013 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$2.27M LATEST DEAL AMOUNT
4 INVESTORS
Description

Operator of a healthcare company intended to offer regenerative medicine. The company's healthcare services include developing a therapeutic compound, ZF143 to help speed tissue healing and stimulate the regeneration of lost or damaged body parts in animals, enabling patients to heal damaged heart tissue caused by heart attacks.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 164 Old Bar Harbor Road
  • Bar Harbor, ME 04609
  • United States

+1 (207) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Novo Biosciences’s full profile, request a free trial.

Novo Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 07-Sep-2017 $2.27M 0000 Completed Startup
4. Grant 01-Jan-2017 00.00 0000 Completed Startup
3. Accelerator/Incubator 0000 Completed Startup
2. Angel (individual) 16-Jul-2015 $75K $75K Completed Startup
1. Grant 17-Nov-2014 $25K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Novo Biosciences Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Maine Technology Institute Other 000 0000 000000 0
MDI Biological Laboratory Accelerator/Incubator 000 0000 000000 0

Novo Biosciences Executive Team (3)

Name Title Board
Seat
Contact
Info
Kevin Strange Ph.D Co-Founder, Chief Executive Officer & Chairman
Voot Yin Ph.D Co-Founder & Chief Scientific Officer
Daniel Coit Advisor

Novo Biosciences Board Members (2)

Name Representing Role Since Contact
Info
Denise Barbut MD Self Board Member 000 0000
Kevin Strange Ph.D Novo Biosciences Co-Founder, Chief Executive Officer & Chairman 000 0000